108 related articles for article (PubMed ID: 10405777)
1. Interaction between endothelin and angiotensin II.
Phillips PA
Clin Exp Pharmacol Physiol; 1999 Jul; 26(7):517-8. PubMed ID: 10405777
[TBL] [Abstract][Full Text] [Related]
2. Endothelin ETA receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats.
De Smet HR; Menadue MF; Oliver JR; Phillips PA
Clin Exp Pharmacol Physiol; 2003 Apr; 30(4):278-83. PubMed ID: 12680847
[TBL] [Abstract][Full Text] [Related]
3. Endothelin receptor antagonists reduce the pressor effects of angiotensin II into the periaqueductal gray area of rats.
D'Amico M; Di Filippo C; Filippelli A; Rossi F
Life Sci; 1999; 65(9):PL95-9. PubMed ID: 10465357
[TBL] [Abstract][Full Text] [Related]
4. Endothelin blockade in angiotensin II hypertension: prevention and treatment studies in the rat.
Ficai S; Herizi A; Mimran A; Jover B
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1100-3. PubMed ID: 11903325
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
Ishiye M; Umemura K; Uematsu T; Nakashima M
Eur J Pharmacol; 1995 Jun; 280(1):11-7. PubMed ID: 7498249
[TBL] [Abstract][Full Text] [Related]
6. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
Ehmke H; Faulhaber J; Münter K; Kirchengast M; Wiesner RJ
Hypertension; 1999 Apr; 33(4):954-60. PubMed ID: 10205230
[TBL] [Abstract][Full Text] [Related]
7. [Bosentan attenuates the hypertensive effect of angiotensin II in rats].
Herizi A; Jover B; Mimran A
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1117-20. PubMed ID: 9404419
[TBL] [Abstract][Full Text] [Related]
8. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
[TBL] [Abstract][Full Text] [Related]
9. Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism.
Mitchell A; Lückebergfeld B; Bührmann S; Rushentsova U; Nürnberger J; Siffert W; Schäfers RF; Philipp T; Wenzel RR
Clin Pharmacol Ther; 2004 Nov; 76(5):396-408. PubMed ID: 15536455
[TBL] [Abstract][Full Text] [Related]
10. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
11. Obligatory role for endogenous endothelin in mediating the hypertrophic effects of phenylephrine and angiotensin II in neonatal rat ventricular myocytes: evidence for two distinct mechanisms for endothelin regulation.
Xia Y; Karmazyn M
J Pharmacol Exp Ther; 2004 Jul; 310(1):43-51. PubMed ID: 15007106
[TBL] [Abstract][Full Text] [Related]
12. Endothelin mediates some of the renal actions of acutely administered angiotensin II.
Riggleman A; Harvey J; Baylis C
Hypertension; 2001 Jul; 38(1):105-9. PubMed ID: 11463769
[TBL] [Abstract][Full Text] [Related]
13. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA
Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Receptor regulation and intracellular Ca2+ modulation.
Fareh J; Touyz RM; Schiffrin EL; Thibault G
Circ Res; 1996 Feb; 78(2):302-11. PubMed ID: 8575074
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of intervention with ETA and ETB receptor antagonists in hypertension induced by angiotensin II and high-salt diet.
Boesen EI; Pollock JS; Pollock DM
Can J Physiol Pharmacol; 2010 Aug; 88(8):802-7. PubMed ID: 20725138
[TBL] [Abstract][Full Text] [Related]
17. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
Pollock DM; Opgenorth TJ
Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
[TBL] [Abstract][Full Text] [Related]
18. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
19. Effects of endothelin receptor antagonism and angiotensin-converting enzyme inhibition on cardiac and renal remodeling in the rat.
Willette RN; Minehart H; Ellison J; Simons T; Short B; Pullen M; Ohlstein EH; Nambi P
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S277-83. PubMed ID: 9595459
[TBL] [Abstract][Full Text] [Related]
20. A role for endothelin ETA receptors in regulation of renal function in spontaneously hypertensive rats.
Bird JE; Webb ML; Giancarli MR; Chao C; Dorso CR; Asaad MM
Eur J Pharmacol; 1995 Dec; 294(1):183-9. PubMed ID: 8788430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
